Artelo Biosciences annual working capital
2015
2016
2017
2018
2019
2020
2021
2021
2022
2023
2024
2025
Artelo Biosciences Working Capital Growth & History (ARTL)
Artelo Biosciences's working capital was −$3.3M for fiscal 2025.
View full Artelo Biosciences company overviewArtelo Biosciences annual working capital history
| Fiscal year | Period ended | Working capital | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$3.3M | −$4.1M | — |
| 2024 | 2024-12-31 | $785,000 | −$8.9M | −91.90% |
| 2023 | 2023-12-31 | $9.7M | −$7.6M | −44.07% |
| 2022 | 2022-12-31 | $17.3M | −$6.3M | −26.54% |
| 2021 · Dec 31 | 2021-12-31 | $23.6M | — | — |
| 2021 · Aug 31 | 2021-08-31 | $9.8M | $8.0M | +433.28% |
| 2020 | 2020-08-31 | $1.8M | −$1.6M | −46.33% |
| 2019 | 2019-08-31 | $3.4M | $3.6M | — |
| 2018 | 2018-08-31 | −$135,537 | −$680,374 | — |
| 2017 | 2017-08-31 | $544,837 | $558,637 | — |
| 2016 | 2016-08-31 | −$13,800 | −$29,090 | — |
| 2015 | 2015-08-31 | $15,290 | — | — |
Artelo Biosciences quarterly working capital
Q2.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Working capital | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.9M | $6.4M | — |
| Q1 2026 | 2026-03-31 | $4.6M | $6.0M | — |
| Q4 2025 | 2025-12-31 | −$3.3M | −$4.1M | — |
| Q3 2025 | 2025-09-30 | −$3.0M | −$7.3M | — |
| Q2 2025 | 2025-06-30 | −$3.5M | −$8.7M | — |
| Q1 2025 | 2025-03-31 | −$1.4M | −$8.9M | — |
| Q4 2024 | 2024-12-31 | $785,000 | −$8.9M | −91.90% |
| Q3 2024 | 2024-09-30 | $4.3M | −$8.2M | −65.71% |
| Q2 2024 | 2024-06-30 | $5.2M | −$8.8M | −62.65% |
| Q1 2024 | 2024-03-31 | $7.5M | −$8.1M | −52.01% |
| Q4 2023 | 2023-12-31 | $9.7M | −$7.6M | −44.07% |
| Q3 2023 | 2023-09-30 | $12.5M | −$7.3M | −36.91% |
| Q2 2023 | 2023-06-30 | $14.0M | −$7.8M | −35.65% |
| Q1 2023 | 2023-03-31 | $15.6M | −$8.2M | −34.38% |
| Q4 2022 | 2022-12-31 | $17.3M | −$6.3M | −26.54% |
| Q3 2022 | 2022-09-30 | $19.8M | — | — |
| Q2 2022 | 2022-06-30 | $21.8M | — | — |
| Q1 2022 · Mar 31 | 2022-03-31 | $23.7M | — | — |
| Q4 2021 · Dec 31 | 2021-12-31 | $23.6M | — | — |
| Q1 2022 · Nov 30 | 2021-11-30 | $24.7M | $17.7M | +252.09% |
| Q4 2021 · Aug 31 | 2021-08-31 | $9.8M | $8.0M | +433.28% |
| Q3 2021 | 2021-05-31 | $9.9M | $8.7M | +734.03% |
| Q2 2021 | 2021-02-28 | $10.8M | $9.1M | +548.85% |
| Q1 2021 | 2020-11-30 | $7.0M | $4.1M | +139.93% |
| Q4 2020 | 2020-08-31 | $1.8M | −$1.6M | −46.33% |
| Q3 2020 | 2020-05-31 | $1.2M | $1.1M | +786.87% |
| Q2 2020 | 2020-02-29 | $1.7M | $2.4M | — |
| Q1 2020 | 2019-11-30 | $2.9M | $3.4M | — |
| Q4 2019 | 2019-08-31 | $3.4M | $3.6M | — |
| Q3 2019 | 2019-05-31 | $133,522 | $225,505 | — |
| Q2 2019 | 2019-02-28 | −$692,588 | −$907,022 | — |
| Q1 2019 | 2018-11-30 | −$475,645 | −$768,856 | — |
| Q4 2018 | 2018-08-31 | −$135,537 | −$680,374 | — |
| Q3 2018 | 2018-05-31 | −$91,983 | $21,961 | — |
| Q2 2018 | 2018-02-28 | $214,434 | $233,906 | — |
| Q1 2018 | 2017-11-30 | $293,211 | $299,671 | — |
| Q4 2017 | 2017-08-31 | $544,837 | $558,637 | — |
| Q3 2017 | 2017-05-31 | −$113,944 | −$104,475 | — |
| Q2 2017 | 2017-02-28 | −$19,472 | −$15,053 | — |
| Q1 2017 | 2016-11-30 | −$6,460 | −$7,131 | — |
| Q4 2016 | 2016-08-31 | −$13,800 | −$29,090 | — |
| Q3 2016 | 2016-05-31 | −$9,469 | — | — |
| Q2 2016 | 2016-02-29 | −$4,419 | −$11,000 | — |
| Q1 2016 | 2015-11-30 | $671 | — | — |
| Q4 2015 | 2015-08-31 | $15,290 | — | — |
| Q2 2015 | 2015-02-28 | $6,581 | — | — |
Artelo Biosciences working capital trends
Between the periods ended 2015-08-31 and 2025-12-31, Artelo Biosciences's working capital decreased from $15,290 to −$3.3M, a change of −$3.4M. The latest reported quarter, Q2 2026, shows $2.9M.
About the metric
What working capital means
Working capital is the difference between current assets and current liabilities. It provides a snapshot of short-term operating liquidity, although negative working capital can be normal for some business models and the measure is often not meaningful for banks.
Calculation and source
How working capital is calculated
TickerStat calculates working capital as reported current assets minus reported current liabilities at the same balance-sheet date. Missing current classifications are not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Artelo Biosciences source filings ↗